Skip to main content
Clinical Trials/DRKS00032191
DRKS00032191RecruitingNot Applicable

Investigation of treatment expectancy in patients with atopic dermatitis undergoing a modern system therapy - ADvance

niversitätsklinikum Essen (AöR), Klinik für Dermatologie, Venerologie und Allergologie0 sites100 target enrollmentStarted: July 3, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • Patients with atopic dermatitis and indication for initiation of systemic therapy.
  • - Women of childbearing potential with contraception (according to the Standard of Care)

Exclusion Criteria

  • - Pregnancy and breast-feeding; lack of willingness to use effective contraception.
  • - Insufficient ability to communicate in the German language or lack of understanding of the German language; dementia or (functional) illiteracy.
  • - Lacking or absent capacity of the patient to give consent
  • - Presence of contraindications to systemic therapy with an IL-4 and IL-13 blocker or a JAK inhibitor.

Investigators

Sponsor
niversitätsklinikum Essen (AöR), Klinik für Dermatologie, Venerologie und Allergologie

Similar Trials